ATOS Stock Analysis: Buy, Sell, or Hold?
ATOS - Atossa Therapeutics, Inc. Common Stock
$0.57
-0.04 (-5.83%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Apr 01, 2026
Smart Money Accumulation
ATOS is down 12.0% this week, but smart money is accumulating calls. Top strike: $0.5 2026-04-17 with 1,191 OI. Call ratio: 94% View Scanner →
Strength: 10.0/10
Get Alerted When ATOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
12 traders called ATOS this week
56% bullish • 7 bearish
56% bullish • 7 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ATOS is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ATOS is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ATOS is currently trading at $0.56, which is considered oversold relative to its 30-day fair value range of $0.60 to $0.67.
Technical Outlook: Technically, ATOS is in a strong downtrend. Immediate support is located at $0.53, while resistance sits at $0.73. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.75 (+858.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATOS is in a strong downtrend. Immediate support is located at $0.53, while resistance sits at $0.73. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.75 (+858.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.60 -
$0.67
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding ATOS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
- BULLISH: Trading 858.3% below Wall St target ($5.75)
- WARNING: Recommendation downgraded due to -12.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.60 -
$0.67
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.53
Resistance Level
$0.73
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.09
Wall Street Target
$5.75
(+858.3%)
Last updated: January 31, 2026 10:49 AM ET
Data refreshes hourly during market hours. Next update: 11:49 AM
Data refreshes hourly during market hours. Next update: 11:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
ATOS is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$35 | 51 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
Advanced ATOS Option Strategies
Professional options setups generated by AI based on today's ATOS price and gamma walls.
